Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (0RKM) Share Forecast & Price Target
0RKM Analyst Ratings
There are no analyst ratings in the last 3 months.
0RKM Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
No analyst ratings match these filters.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
0RKM Financial Forecast
0RKM Earnings Forecast
Next quarter’s earnings estimate for 0RKM is PLN 0.06 with a range of ― to ―. The previous quarter’s EPS was ―. 0RKM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0RKM has Performed in-line its overall industry.
0RKM Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.?
To buy shares of GB:0RKM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.